Tolerance.ca
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

UK's GlaxoSmithKline aims to market first malaria vaccine

Malaria kills hundreds of thousands of people every year, mostly babies in sub-Saharan Africa. This child in Tanzania is taking part in a trial for the world's first malaria vaccine RTS,S Britain's GlaxoSmithKline is hoping to get marketing approval for the injection next year after the trial significantly cut cases in children. Scientists say an effective vaccine is key for eradicating malaria. Doctor Allan Pamba helped carry out the trial for GSK. SOUNDBITE: Allan Pamba, GSK doctor, saying (English): "The vaccine reduces by about half the risk of malaria for children between 5 and 17 months and by about a quarter for children 6 - 12 weeks. It's a huge population of children we've been following, about 15,000 across 11 sites in 7 countries across Africa." If drug regulators give it the green light, the World Health Organisation may recommend use of the vaccine in two years' time. But getting it to patients won't be easy, says Mark Hollis

© DailyMotion -


Comment on this article!
To post a comment, we encourage you to become a member of Tolerance.ca® or log in if you are already a member. You can still post your commentwithout registering, but you will need to fill your personal information each time.

Become a member (free)   |   Log in

Postings are subject to the terms and conditions of Tolerance.ca®. Before submitting your message , you must read the Terms and conditions of Tolerance.ca® and agree to them by checking the box below.
Your name:
Email:
Heading:
Message:
 
  I have read and agree to the Terms and conditions of Tolerance.ca®.
Follow us on ...
Facebook Twitter